0001209191-20-013039.txt : 20200226 0001209191-20-013039.hdr.sgml : 20200226 20200226163923 ACCESSION NUMBER: 0001209191-20-013039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tatsis Ourania CENTRAL INDEX KEY: 0001789815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20656362 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001789815 Tatsis Ourania C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP, CRO Common Stock 2020-02-24 4 F 0 1036 239.23 D 14034 D Common Stock 2020-02-25 4 S 0 416 229.57 D 13618 D Common Stock 2020-02-25 4 S 0 160 231.82 D 13458 D Common Stock 2020-02-25 4 S 0 80 232.43 D 13378 D Common Stock 2020-02-25 4 S 0 240 234.43 D 13138 D Common Stock 2020-02-25 4 S 0 160 235.39 D 12978 D Common Stock 2020-02-25 4 S 0 240 237.81 D 12738 D Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $229.57 (range $229.15 to $229.91). Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $231.82 (range $231.27 to $232.37). Open market sales reported on this line occurred at a weighted average price of $234.43 (range $234.14 to $234.89). Open market sales reported on this line occurred at a weighted average price of $235.39 (range $235.33 to $235.44). Open market sales reported on this line occurred at a weighted average price of $237.81 (range $237.24 to $238.18). /s/ Omar White, Attorney-in-Fact 2020-02-26